scholarly journals Treatment of a flunixin meglumine overdose with intravenous administration of lipid emulsion and therapeutic plasma exchange in a Nigerian dwarf buck kid ( Capra aegagrus hircus )

2021 ◽  
Author(s):  
Emmanuelle Marie Butty ◽  
Caroline Ann McKinney ◽  
Amanda Jane Prisk
Keyword(s):  
Plasma Exchange ◽  
Intravenous Administration ◽  
Lipid Emulsion ◽  
Therapeutic Plasma Exchange ◽  
Flunixin Meglumine ◽  
Capra Aegagrus

scholarly journals Therapeutic plasma exchange to mitigate flunixin meglumine overdose in a cria

2021 ◽  
Author(s):  
Claire E. Dixon ◽  
Denise Kelley ◽  
Jacob Michael Froehlich ◽  
Alisha Gruntman ◽  
Trisha Oura ◽  
...  
Keyword(s):  
Plasma Exchange ◽  
Therapeutic Plasma Exchange ◽  
Flunixin Meglumine

Therapeutic Plasma Exchange Application in Children Requires Individual Decision

2020 ◽  
Author(s):  
Gürkan Atay ◽  
Demet Demirkol
Keyword(s):  
Plasma Exchange ◽  
Vascular Access ◽  
Pediatric Patients ◽  
Demyelinating Disease ◽  
Pediatric Intensive Care ◽  
Therapeutic Plasma Exchange ◽  
Transplantation Rejection ◽  
Access Problems ◽  
Uremic Syndrome

AbstractTherapeutic plasma exchange (TPE) is a treatment administered with the aim of removing a pathogenic material or compound causing morbidity in a variety of neurologic, hematologic, renal, and autoimmune diseases. In this study, we aimed to assess the indications, efficacy, reliability, complications, and treatment response of pediatric patients for TPE. This retrospective study analyzed data from 39 patients aged from 0 to 18 years who underwent a total of 172 TPE sessions from January 2015 to April 2018 in a tertiary pediatric intensive care unit. Indications for TPE were, in order of frequency, macrophage activation syndrome (28.2%, n = 11), renal transplantation rejection (15.4%, n = 6), liver failure (15.4%, n = 6), Guillain–Barre's syndrome (15%, n = 6), hemolytic uremic syndrome (7.7%, n = 3), acute demyelinating disease (7.7%, n = 3), septic shock (5.1%, n = 2), and intoxication (5.1%, n = 2). No patient had any adverse event related to the TPE during the procedure. The TPE session was ended prematurely in one patient due to insufficient vascular access and lack of blood flow (2.6%). In the long term, thrombosis due to the indwelling central catheter occurred (5.1%, n = 2). TPE appears to be an effective first-stage or supplementary treatment in a variety of diseases, may be safely used in pediatric patients, and there are significant findings that its area of use will increase. In experienced hands and when assessed carefully, it appears that the rate of adverse reactions and vascular access problems may be low enough to be negligible.

Therapeutic plasma exchange in intensive care and intensive nephrology

2018 ◽  
Vol 20 (4) ◽  
pp. 394-403
Author(s):  
M. S. Vetsheva ◽  
◽  
K.E Loss . ◽  
O.L. Podkorytova ◽  
E.V. Lebedkov ◽  
...  
Keyword(s):  
Intensive Care ◽  
Plasma Exchange ◽  
Therapeutic Plasma Exchange

Therapeutic plasma exchange in a single center: Ibni Sina experience

2004 ◽  
Vol 30 (3) ◽  
pp. 181-184 ◽  
Author(s):  
Önder Arslan ◽  
Mutlu Arat ◽  
Ibrahim Tek ◽  
Erol Ayyildiz ◽  
Osman Ilhan
Keyword(s):  
Plasma Exchange ◽  
Therapeutic Plasma Exchange ◽  
Single Center

scholarly journals Therapeutic plasma exchange for persistent encephalopathy associated with Covid-19

2021 ◽  
Vol 22 ◽  
pp. 100327
Author(s):  
Chakrapani Ranganathan ◽  
Shelley D. Fusinski ◽  
Imad M. Obeid ◽  
Khaled M. Ismail ◽  
Derrick T. Ferguson ◽  
...  
Keyword(s):  
Plasma Exchange ◽  
Therapeutic Plasma Exchange
Sign in / Sign up

Export Citation Format

Share Document